Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Omega-3 Drug Firm’s Trade Complaint Questions US Dietary Ingredient Standards

Sep 05 2017

• By Malcolm Spicer

Related Content

Amarin Seeks ITC Action Against Products 'Cloaked' As Dietary Supplements

Aug 30 2017

Will The Rising Tide Of Rx Omega-3s Float The Fish Oil Supplement Market?

Jan 26 2011

FDA's Initial IND Warnings For CBD Supplements Could Ignite Regulatory Test

Feb 16 2016

Amarin Decision Could Spur Pressure Against FDA On Supplement Claim Policy

Aug 24 2015

‘Old’ Ingredient List On FDA Table Could Spur New Supplement Launches

Aug 14 2017

Hatch Questions FDA Motive, Process In Proposed Vinpocetine Ban

Nov 01 2016

Herbal Sleep Aid With Rx 'Reformulation' Gives FDA A Nightmare

Jun 15 2017

Off-Label Promotion Settlement Includes Optional Preclearance Process

Mar 09 2016

Related Companies

Amarin Corp plc

Royal DSM N.V.

GSK plc

Royal DSM N.V.

Otsuka Holdings Co., Ltd.

Additional Topics

International United States Dietary Supplements Legal Issues FDA Manufacturing Advertising, Marketing & Sales Trade Policy Consumer

More from Legal

More from Policy & Regulation

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window